tiprankstipranks
Trending News
More News >
ESSA Pharma Inc. (EPIX)
:EPIX
US Market

ESSA Pharma (EPIX) Income Statement

Compare
Followers

ESSA Pharma Income Statement

Last quarter (Q3 2025), ESSA Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, ESSA Pharma's net income was $-4.00M. See ESSA Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -90.68K$ -118.49K$ -121.79K$ -109.46K$ -110.32K
Operating Expenses
$ 34.42M$ 32.13M$ 36.96M$ 37.14M$ 23.52M
Depreciation and Amortization
$ 90.68K$ 118.49K$ 121.79K$ 109.46K$ 110.32K
EBITDA
$ -28.45M$ -26.46M$ -35.08M$ -36.71M$ -23.01M
Operating Income
$ -34.42M$ -32.13M$ -35.34M$ -36.91M$ -23.12M
Other Income/Expenses
$ 5.88M$ 5.55M$ 1.74M$ 303.76K$ -214.10K
Pretax Income
$ -28.54M$ -26.58M$ -35.22M$ -36.84M$ -23.73M
Net Income
$ -28.54M$ -26.58M$ -35.10M$ -36.81M$ -23.45M
Per Share Metrics
Basic EPS
$ -0.64$ -0.60$ -0.80$ -0.96$ -1.04
Diluted EPS
$ -0.64$ -0.60$ -0.80$ -0.96$ -1.04
Weighted Average Shares Outstanding
44.28M 44.09M 44.04M 38.48M 22.44M
Weighted Average Shares Outstanding (Diluted)
44.28M 44.09M 44.04M 38.48M 22.44M
Currency in USD

ESSA Pharma Earnings and Revenue History